[
    {
        "link": "https://www.who.int/indonesia/news/detail/15-11-2024-who--unfpa-commend-indonesia-s-efforts-to-eliminate-cervical-cancer--urge-streamlined-vaccine-strategy-and-enhanced-screening",
        "date": "15 November 2024",
        "title": "WHO, UNFPA commend Indonesia\u2019s efforts to eliminate cervical cancer, urge streamlined vaccine strategy and enhanced screening",
        "thumbnail": "https://cdn.who.int/media/images/default-source/cover-images/who-iqbal-lubis-compressed.tmb-768v.jpeg?sfvrsn=9b00d9dc_2",
        "content": "<div><p><strong>Jakarta, 15 November 2024</strong> \u2013 Ahead of the 17 November Cervical Cancer Elimination Day of Action, the World Health Organization (WHO) and United Nations Population Fund (UNFPA) commend the Indonesian Ministry of Health (MoH) for its commitment to eliminate cervical cancer, marked by the 2023 national human papillomavirus (HPV) vaccine rollout and the shift to HPV DNA testing. The UN agencies, which supported the country\u2019s first National Cervical Cancer Elimination Plan (NCCEP) 2023\u20132030, will continue to help implement the Plan through primary health care programmes, hospital partnerships and the introduction of evidence-based, cost-effective innovations.</p><p>Globally, cervical cancer is the fourth most common cancer in women. In 2022 an estimated 660 000 women were diagnosed with cervical cancer worldwide. About 350 000 women died from the disease. Almost all cervical cancer cases (99%) are linked with HPV infection.</p><p>Cervical cancer is the second most common cancer among Indonesian women, with about 36 000 new cases and 21 000 deaths annually. Indonesia\u2019s 2023 decision to expand HPV vaccine access to girls in grades 5 and 6 \u2013 in alignment with the NCCEP \u2013 marks a major step forward in meeting the targets of the WHO Global Strategy for cervical cancer elimination as a public health problem, set for 2030.</p><p>The global targets require:</p><ul><li>90% of girls to be vaccinated with the HPV vaccine by age 15 </li><li>70% of women to be screened with a high-performance test by ages 35 and 45</li><li>90% of women with pre-cancer to receive treatment and 90% of women with invasive cancer to be managed. \u00a0</li></ul><p>WHO and UNFPA congratulate Indonesia for adopting these targets nationally. To accelerate progress, WHO stands ready to support Indonesia to adopt a streamlined, single-dose HPV vaccine schedule, which offers comparable protection to the current two-dose schedule, reduces costs and reaches more girls and women faster.</p><p>\u201cIndonesia\u2019s national HPV vaccine rollout represents a significant commitment to public health and gender equity,\u201d said Dr N. Paranietharan, WHO Representative to Indonesia. \u201cThe single-dose schedule will bring greater efficiency, lower costs and accelerate protection for Indonesian girls and women, advancing our shared goal of eliminating cervical cancer.\u201d</p><p>Globally, 141 countries have integrated the HPV vaccine into their routine immunization programmes, with 59 adopting a single-dose policy, including South Africa, Canada, the United Kingdom and Australia. The recommendation for single-dose scheduling was initially made in April 2022, by WHO\u2019s independent expert advisory group, SAGE<strong>.</strong></p><h2><strong>Expanding equitable access to screening and treatment</strong></h2><p>Concurrently, WHO and UNFPA commend Indonesia\u2019s efforts to increase equitable access to cancer screening and treatment services that are responsive to women's specific needs. This is vital to improve cervical cancer early detection and treatment success rates and must continue to be scaled up. Currently, about 70% of cervical cancers in Indonesia are diagnosed at an advanced stage, when treatment is less effective. </p><p>By repurposing existing RT-PCR systems from the COVID-19 response, and by expanding the use of GeneXpert machines for HPV testing, MoH is ensuring more Indonesian women can access early and effective diagnosis and treatment. WHO will continue to help adapt national service standards and protocols in line with the latest evidence-based guidance. \u00a0</p><p>As part of these efforts, UNFPA will continue to provide vital support to increase access to quality primary care, which is critical for cervical cancer screening. \"UNFPA Indonesia is dedicated to supporting midwives in Indonesia to reach international standards,\u201d said Hassan Mohtashami, UNFPA Indonesia Representative. \u201cBy providing training and continuing professional development of this important workforce, we empower these healthcare providers to detect and prevent cervical cancer, ultimately saving the lives of Indonesian women.\"</p><p>Indonesia\u2019s forthcoming comprehensive National Cancer Control Plan (NCCP) 2024\u20132034 will complement and support the 2023 National Cervical Cancer Elimination Plan, particularly in strengthening service delivery, education and training among health workers, which is critical to accelerate progress against all cancers, including cervical cancer. \u00a0</p><p>The NCCP is informed by Indonesia\u2019s third Integrated Mission of the Programme of Action for Cancer Therapy (imPACT) review, which was conducted in 2024 with support from WHO, the International Agency for Atomic Energy and the International Agency for Research on Cancer.</p><p>\u201cWhere there\u2019s a will, there\u2019s often a way forward \u2013 and with cervical cancer, we have both,\u201d said Dr Paranietharan. \u201cTogether, WHO and its partners are committed to support Indonesia to eliminate cervical cancer as a public health problem, in our time, on our watch.\u201d \u00a0</p><p></p></div><p><strong>Jakarta, 15 November 2024</strong> \u2013 Ahead of the 17 November Cervical Cancer Elimination Day of Action, the World Health Organization (WHO) and United Nations Population Fund (UNFPA) commend the Indonesian Ministry of Health (MoH) for its commitment to eliminate cervical cancer, marked by the 2023 national human papillomavirus (HPV) vaccine rollout and the shift to HPV DNA testing. The UN agencies, which supported the country\u2019s first National Cervical Cancer Elimination Plan (NCCEP) 2023\u20132030, will continue to help implement the Plan through primary health care programmes, hospital partnerships and the introduction of evidence-based, cost-effective innovations.</p><strong>Jakarta, 15 November 2024</strong><p>Globally, cervical cancer is the fourth most common cancer in women. In 2022 an estimated 660 000 women were diagnosed with cervical cancer worldwide. About 350 000 women died from the disease. Almost all cervical cancer cases (99%) are linked with HPV infection.</p><p>Cervical cancer is the second most common cancer among Indonesian women, with about 36 000 new cases and 21 000 deaths annually. Indonesia\u2019s 2023 decision to expand HPV vaccine access to girls in grades 5 and 6 \u2013 in alignment with the NCCEP \u2013 marks a major step forward in meeting the targets of the WHO Global Strategy for cervical cancer elimination as a public health problem, set for 2030.</p><p>The global targets require:</p><ul><li>90% of girls to be vaccinated with the HPV vaccine by age 15 </li><li>70% of women to be screened with a high-performance test by ages 35 and 45</li><li>90% of women with pre-cancer to receive treatment and 90% of women with invasive cancer to be managed. \u00a0</li></ul><li>90% of girls to be vaccinated with the HPV vaccine by age 15 </li><li>70% of women to be screened with a high-performance test by ages 35 and 45</li><li>90% of women with pre-cancer to receive treatment and 90% of women with invasive cancer to be managed. \u00a0</li><p>WHO and UNFPA congratulate Indonesia for adopting these targets nationally. To accelerate progress, WHO stands ready to support Indonesia to adopt a streamlined, single-dose HPV vaccine schedule, which offers comparable protection to the current two-dose schedule, reduces costs and reaches more girls and women faster.</p><p>\u201cIndonesia\u2019s national HPV vaccine rollout represents a significant commitment to public health and gender equity,\u201d said Dr N. Paranietharan, WHO Representative to Indonesia. \u201cThe single-dose schedule will bring greater efficiency, lower costs and accelerate protection for Indonesian girls and women, advancing our shared goal of eliminating cervical cancer.\u201d</p><p>Globally, 141 countries have integrated the HPV vaccine into their routine immunization programmes, with 59 adopting a single-dose policy, including South Africa, Canada, the United Kingdom and Australia. The recommendation for single-dose scheduling was initially made in April 2022, by WHO\u2019s independent expert advisory group, SAGE<strong>.</strong></p><strong>.</strong><h2><strong>Expanding equitable access to screening and treatment</strong></h2><strong>Expanding equitable access to screening and treatment</strong><p>Concurrently, WHO and UNFPA commend Indonesia\u2019s efforts to increase equitable access to cancer screening and treatment services that are responsive to women's specific needs. This is vital to improve cervical cancer early detection and treatment success rates and must continue to be scaled up. Currently, about 70% of cervical cancers in Indonesia are diagnosed at an advanced stage, when treatment is less effective. </p><p>By repurposing existing RT-PCR systems from the COVID-19 response, and by expanding the use of GeneXpert machines for HPV testing, MoH is ensuring more Indonesian women can access early and effective diagnosis and treatment. WHO will continue to help adapt national service standards and protocols in line with the latest evidence-based guidance. \u00a0</p><p>As part of these efforts, UNFPA will continue to provide vital support to increase access to quality primary care, which is critical for cervical cancer screening. \"UNFPA Indonesia is dedicated to supporting midwives in Indonesia to reach international standards,\u201d said Hassan Mohtashami, UNFPA Indonesia Representative. \u201cBy providing training and continuing professional development of this important workforce, we empower these healthcare providers to detect and prevent cervical cancer, ultimately saving the lives of Indonesian women.\"</p><p>Indonesia\u2019s forthcoming comprehensive National Cancer Control Plan (NCCP) 2024\u20132034 will complement and support the 2023 National Cervical Cancer Elimination Plan, particularly in strengthening service delivery, education and training among health workers, which is critical to accelerate progress against all cancers, including cervical cancer. \u00a0</p><p>The NCCP is informed by Indonesia\u2019s third Integrated Mission of the Programme of Action for Cancer Therapy (imPACT) review, which was conducted in 2024 with support from WHO, the International Agency for Atomic Energy and the International Agency for Research on Cancer.</p><p>\u201cWhere there\u2019s a will, there\u2019s often a way forward \u2013 and with cervical cancer, we have both,\u201d said Dr Paranietharan. \u201cTogether, WHO and its partners are committed to support Indonesia to eliminate cervical cancer as a public health problem, in our time, on our watch.\u201d \u00a0</p><p></p>"
    },
    {
        "link": "https://www.who.int/indonesia/news/detail/13-11-2024-indonesia-takes-leadership-role-in-tackling-tb-with-development-of-new-vaccine-candidates",
        "date": "13 November 2024",
        "title": "Indonesia takes leadership role in tackling TB with development of new vaccine candidates",
        "thumbnail": "https://cdn.who.int/media/images/default-source/cover-images/amrtbparan.tmb-768v.png?sfvrsn=57cd3d06_2",
        "content": "<div><p><strong>Bali, 13 November 2024 \u2013</strong> On 8\u20139 November 2024, the World Health Organization (WHO) and Indonesian Ministry of Health convened for the first national consultation on new tuberculosis (TB) vaccines in Bali. Held ahead of the Union World Conference on Lung Health, the meeting focused on the potential impact of new TB vaccines for adults and adolescents, programmatic use considerations, potential financing scenarios and evidence needs for vaccine introduction in Indonesia. The meeting is part of an effort to expedite the development of new TB vaccines for adults and adolescents, and to prepare for their financing and access as part of the <a data-sf-ec-immutable=\"\" href=\"https://www.who.int/initiatives/tuberculosis-vaccine-accelerator-council\">TB Vaccine Accelerator Council</a>.</p><p>New TB vaccines are urgently needed to tackle the TB burden in Indonesia and globally. For this reason, Indonesia is participating in a Phase 3 clinical trial for the most advanced TB vaccine candidate in development, M72/AS01E. If successful, this could mark the first TB vaccine to be approved in over 100 years. Preliminary results have shown that the vaccine meets <a data-sf-ec-immutable=\"\" href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/product-and-delivery-research/ppcs\">WHO\u2019s preferred product characteristics</a>. If its efficacy is confirmed in this late-stage trial, it could lead to the introduction of a new TB vaccine for adults and adolescents by 2030. </p><p>Commenting on the meeting, Minister of Health, Budi Gunadi Sadikin, said: \"The president has entrusted me with accelerating our response to reduce the burden of TB by 50% in five years. Well over a million lives are lost to TB globally every year, and the number of deaths caused by TB in the last decade far surpasses the death toll of COVID-19. With the arrival of new TB vaccines, we have a critical opportunity to strengthen our efforts and save more lives.\"</p><p>Director General of Pharmaceuticals and Medical Devices, Rizka Andalusia<strong>,</strong> said: <w:sdt id=\"-2053218382\" sdttag=\"goog_rdk_1\"></w:sdt>\"Indonesia is proud to actively participate in the Phase 3 clinical trial of the M72/AS01E vaccine candidate, which could represent a major breakthrough in the global fight against TB. By contributing to the development of this promising vaccine, we are not only taking a crucial step toward protecting our own population but also helping to advance a solution that could save millions of lives worldwide. Our involvement in this trial reflects Indonesia\u2019s commitment to accelerate progress to reduce the TB burden and support innovative tools that can bring us closer to eliminating this disease.\"</p><p>The meeting also brought together representatives from the Coordinating Ministry for Community Empowerment, Indonesia\u2019s TB Expert Committee, Stop TB Indonesia, the Gates Foundation, Wellcome, Global Health Strategies Indonesia and other key national, regional and global stakeholders. Participants discussed TB vaccine research, policy planning and the future integration of new TB vaccines into Indonesia\u2019s National Immunization Strategy (NIS), thereby accelerating early adoption.</p><p>WHO Representative to Indonesia, Dr N. Paranietharan,<strong> </strong>said: \"Indonesia's commitment to fighting TB is impressive, as demonstrated by its participation in the development and clinical testing of new TB vaccine candidates. These promising candidates, many of which are now in late-stage trials, could significantly reduce TB transmission and save millions of lives. WHO is proud to work with Indonesia and other high TB-burden countries to make these vaccines available and integrate them into national health programmes. Together, we can take a critical step toward ending TB and building a healthier future.\"</p><h2><strong>New TB vaccines: A priority for Indonesia\u2019s National Immunization Strategy</strong></h2><p>The <a data-sf-ec-immutable=\"\" href=\"https://www.who.int/teams/global-tuberculosis-programme/tb-reports\">2024 Global TB Report</a> confirms that the highest incidence and transmission occurs in adult and adolescent populations. Modelling suggests that a TB vaccine for adolescents and adults that is 50% effective in preventing disease is expected to prevent between 37 and 76 million cases and save 4.6 to 8.5 million lives by 2050 globally. For infants, an improved vaccine with 80% efficacy could prevent 5.8 to 18.8 million cases and save 0.8 to 2.6 million lives in the same timeframe. </p><p>These findings show that a safe and effective TB vaccine could significantly reduce the number of TB cases and deaths, with vaccines for adolescents and adults having a bigger impact than those for infants. The effectiveness of a vaccine depends on how well it works, how long it provides protection, who it is delivered to, and how widely it is distributed.<br/></p><p>The introduction of new TB vaccines is a key element of Indonesia\u2019s NIS, which outlines the country\u2019s immunization goals over the next five years. Investing in TB vaccines, including in the support systems needed for effective access and delivery, is not only critical for health but also highly cost-effective in most countries. WHO estimates that for every US$ 1 dollar invested in TB vaccines, there will be a sevenfold return in health and economic benefits globally over the next 25 years.<br/></p><p>\u201cAs we know from the history of global epidemics and elimination of some communicable diseases, it cannot be possible without effective vaccines. And new TB vaccines may become real game-changers in the fight against this millennia-old disease, which kills and brings suffering to millions of people worldwide,\u2019\u2019 added Dr Tereza Kasaeva, Director, WHO Global TB Programme.<br/></p><p>The meeting identified key data and evidence gaps that must be addressed to inform Indonesia\u2019s decision-making, as well as critical opportunities to accelerate the introduction of new safe and effective TB vaccines in the country. The Government of Indonesia\u2019s active participation in these trials and discussions positions the nation as a leader in the global effort to eliminate TB.</p><p>\u00a0</p><p>\u00a0</p></div><p><strong>Bali, 13 November 2024 \u2013</strong> On 8\u20139 November 2024, the World Health Organization (WHO) and Indonesian Ministry of Health convened for the first national consultation on new tuberculosis (TB) vaccines in Bali. Held ahead of the Union World Conference on Lung Health, the meeting focused on the potential impact of new TB vaccines for adults and adolescents, programmatic use considerations, potential financing scenarios and evidence needs for vaccine introduction in Indonesia. The meeting is part of an effort to expedite the development of new TB vaccines for adults and adolescents, and to prepare for their financing and access as part of the <a data-sf-ec-immutable=\"\" href=\"https://www.who.int/initiatives/tuberculosis-vaccine-accelerator-council\">TB Vaccine Accelerator Council</a>.</p><strong>Bali, 13 November 2024 \u2013</strong><a data-sf-ec-immutable=\"\" href=\"https://www.who.int/initiatives/tuberculosis-vaccine-accelerator-council\">TB Vaccine Accelerator Council</a><p>New TB vaccines are urgently needed to tackle the TB burden in Indonesia and globally. For this reason, Indonesia is participating in a Phase 3 clinical trial for the most advanced TB vaccine candidate in development, M72/AS01E. If successful, this could mark the first TB vaccine to be approved in over 100 years. Preliminary results have shown that the vaccine meets <a data-sf-ec-immutable=\"\" href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/product-and-delivery-research/ppcs\">WHO\u2019s preferred product characteristics</a>. If its efficacy is confirmed in this late-stage trial, it could lead to the introduction of a new TB vaccine for adults and adolescents by 2030. </p><a data-sf-ec-immutable=\"\" href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/product-and-delivery-research/ppcs\">WHO\u2019s preferred product characteristics</a><p>Commenting on the meeting, Minister of Health, Budi Gunadi Sadikin, said: \"The president has entrusted me with accelerating our response to reduce the burden of TB by 50% in five years. Well over a million lives are lost to TB globally every year, and the number of deaths caused by TB in the last decade far surpasses the death toll of COVID-19. With the arrival of new TB vaccines, we have a critical opportunity to strengthen our efforts and save more lives.\"</p><p>Director General of Pharmaceuticals and Medical Devices, Rizka Andalusia<strong>,</strong> said: <w:sdt id=\"-2053218382\" sdttag=\"goog_rdk_1\"></w:sdt>\"Indonesia is proud to actively participate in the Phase 3 clinical trial of the M72/AS01E vaccine candidate, which could represent a major breakthrough in the global fight against TB. By contributing to the development of this promising vaccine, we are not only taking a crucial step toward protecting our own population but also helping to advance a solution that could save millions of lives worldwide. Our involvement in this trial reflects Indonesia\u2019s commitment to accelerate progress to reduce the TB burden and support innovative tools that can bring us closer to eliminating this disease.\"</p><strong>,</strong><w:sdt id=\"-2053218382\" sdttag=\"goog_rdk_1\"></w:sdt><p>The meeting also brought together representatives from the Coordinating Ministry for Community Empowerment, Indonesia\u2019s TB Expert Committee, Stop TB Indonesia, the Gates Foundation, Wellcome, Global Health Strategies Indonesia and other key national, regional and global stakeholders. Participants discussed TB vaccine research, policy planning and the future integration of new TB vaccines into Indonesia\u2019s National Immunization Strategy (NIS), thereby accelerating early adoption.</p><p>WHO Representative to Indonesia, Dr N. Paranietharan,<strong> </strong>said: \"Indonesia's commitment to fighting TB is impressive, as demonstrated by its participation in the development and clinical testing of new TB vaccine candidates. These promising candidates, many of which are now in late-stage trials, could significantly reduce TB transmission and save millions of lives. WHO is proud to work with Indonesia and other high TB-burden countries to make these vaccines available and integrate them into national health programmes. Together, we can take a critical step toward ending TB and building a healthier future.\"</p><strong> </strong><h2><strong>New TB vaccines: A priority for Indonesia\u2019s National Immunization Strategy</strong></h2><strong>New TB vaccines: A priority for Indonesia\u2019s National Immunization Strategy</strong><p>The <a data-sf-ec-immutable=\"\" href=\"https://www.who.int/teams/global-tuberculosis-programme/tb-reports\">2024 Global TB Report</a> confirms that the highest incidence and transmission occurs in adult and adolescent populations. Modelling suggests that a TB vaccine for adolescents and adults that is 50% effective in preventing disease is expected to prevent between 37 and 76 million cases and save 4.6 to 8.5 million lives by 2050 globally. For infants, an improved vaccine with 80% efficacy could prevent 5.8 to 18.8 million cases and save 0.8 to 2.6 million lives in the same timeframe. </p><a data-sf-ec-immutable=\"\" href=\"https://www.who.int/teams/global-tuberculosis-programme/tb-reports\">2024 Global TB Report</a><p>These findings show that a safe and effective TB vaccine could significantly reduce the number of TB cases and deaths, with vaccines for adolescents and adults having a bigger impact than those for infants. The effectiveness of a vaccine depends on how well it works, how long it provides protection, who it is delivered to, and how widely it is distributed.<br/></p><br/><p>The introduction of new TB vaccines is a key element of Indonesia\u2019s NIS, which outlines the country\u2019s immunization goals over the next five years. Investing in TB vaccines, including in the support systems needed for effective access and delivery, is not only critical for health but also highly cost-effective in most countries. WHO estimates that for every US$ 1 dollar invested in TB vaccines, there will be a sevenfold return in health and economic benefits globally over the next 25 years.<br/></p><br/><p>\u201cAs we know from the history of global epidemics and elimination of some communicable diseases, it cannot be possible without effective vaccines. And new TB vaccines may become real game-changers in the fight against this millennia-old disease, which kills and brings suffering to millions of people worldwide,\u2019\u2019 added Dr Tereza Kasaeva, Director, WHO Global TB Programme.<br/></p><br/><p>The meeting identified key data and evidence gaps that must be addressed to inform Indonesia\u2019s decision-making, as well as critical opportunities to accelerate the introduction of new safe and effective TB vaccines in the country. The Government of Indonesia\u2019s active participation in these trials and discussions positions the nation as a leader in the global effort to eliminate TB.</p><p>\u00a0</p><p>\u00a0</p>"
    },
    {
        "link": "https://www.who.int/indonesia/news/detail/28-09-2024-prevent-every-rabies-death--who-and-fao-highlight-need-for-urgent--comprehensive-action-on-world-rabies-day-2024",
        "date": "28 September 2024",
        "title": "Prevent every rabies death: WHO and FAO highlight need for urgent, comprehensive action on World Rabies Day 2024",
        "thumbnail": "https://cdn.who.int/media/images/default-source/cover-images/mass-dog-vaccination.tmb-768v.jpg?sfvrsn=bdf30c6f_2",
        "content": "<div><p><strong>Jakarta, 28 September 2024 \u2013</strong> The World Health Organization (WHO) and Food and Agriculture Organization of the United Nations (FAO) are today calling for comprehensive action across Indonesia to stop rabies deaths in humans, emphasizing that every rabies death is preventable. The UN agencies are urging both personal protective measures and increased One Health action, including for mass dog vaccination and integrated bite case management.\u00a0 \u00a0</p><p>Rabies is a vaccine-preventable, zoonotic viral disease that affects the central nervous system. In up to 99% of human rabies cases, dogs are responsible for virus transmission, primarily through bites. Once clinical symptoms appear, rabies is almost 100% fatal. In Indonesia, children under the age of 15 are frequent rabies victims.</p><p>Between January 2024 and July 2024, publicly accessible data show that 71 Indonesians have died from rabies. Among Indonesia\u2019s 26 rabies-endemic provinces, East Nusa Tenggara (NTT) is the most affected, with 19 320 cases of potentially rabid animal bites in humans in 2023. This resulted in 35 rabies deaths. From January to July 2024, NTT reported 16 180 cases of potentially rabid animal bites and 27 rabies deaths.\u00a0 </p><p>\u201cCommunities in rabies-affected provinces must be empowered with both knowledge of and access to life-saving interventions,\u201d said Dr N. Paranietharan, WHO Representative to Indonesia. \u201cSince the beginning of 2023, almost 4 out of 5 Indonesians who died from rabies had not sought medical care after being bitten, simply because they were unaware of the need to do so. This must be addressed \u2013 urgently, decisively, and comprehensively.\u201d</p><p>Any person bitten by a dog should:</p><ul><li>Immediately wash the wound with water and soap or detergent. If water and soap or detergent are unavailable, alcohol can also be effective.</li><li>Fifteen minutes after washing the wound, apply an iodine-containing or anti-viral medication, if available.</li><li>Seek treatment as soon as possible from a healthcare professional and complete all doses of rabies vaccine.</li></ul><p>Across rabies-endemic provinces, WHO will continue to support the Ministry of Health to increase awareness of personal protective and first-aid measures, improve health worker capacity in bite case management, and enhance access to health facilities equipped with anti-rabies vaccine. </p><p>In 2024, WHO has supported bite case management training for health workers in Pontianak, West Kalimantan and is currently developing a social and behaviour change campaign in NTT specifically.</p><p>However, to prevent and eliminate dog-mediated rabies in people, mass dog vaccination \u2013 supported by effective dog population management \u2013 is the most cost-effective and efficient strategy. Globally, it has been shown that control of canine rabies can be achieved with sustained dog vaccination coverage of 70%.\u00a0</p><p>\u201cIndonesia is making progress towards rabies elimination. To further accelerate this effort, FAO is supporting the Government of Indonesia to develop a strategic operational plan for rabies elimination in Java, Bali, West Nusa Tenggara and NTT,\u201d said Rajendra Aryal, FAO Representative for Indonesia and Timor-Leste.</p><p>One of the key strategies being piloted in these areas is oral rabies vaccination, which targets free-roaming dogs. This complements traditional mass dog vaccination programmes and aims to address challenges in reaching these dog populations. \u201cFAO remains committed to supporting Indonesia's rabies control efforts,\u201d added Aryal.</p><p>WHO and FAO will continue to support Indonesia to end human rabies deaths by 2030, in alignment with the global \u201cZero by 30\u201d strategy, which targets both animal and human health sectors. </p><p>By implementing the strategy, affected countries will move closer to achieving Sustainable Development Goal (SDG) 3.3, \u201cBy 2030, end the epidemics of neglected tropical diseases\u201d, and make progress towards meeting SDG 3.8 on achieving universal health coverage.<strong></strong></p><p><strong>\u00a0</strong></p></div><p><strong>Jakarta, 28 September 2024 \u2013</strong> The World Health Organization (WHO) and Food and Agriculture Organization of the United Nations (FAO) are today calling for comprehensive action across Indonesia to stop rabies deaths in humans, emphasizing that every rabies death is preventable. The UN agencies are urging both personal protective measures and increased One Health action, including for mass dog vaccination and integrated bite case management.\u00a0 \u00a0</p><strong>Jakarta, 28 September 2024 \u2013</strong><p>Rabies is a vaccine-preventable, zoonotic viral disease that affects the central nervous system. In up to 99% of human rabies cases, dogs are responsible for virus transmission, primarily through bites. Once clinical symptoms appear, rabies is almost 100% fatal. In Indonesia, children under the age of 15 are frequent rabies victims.</p><p>Between January 2024 and July 2024, publicly accessible data show that 71 Indonesians have died from rabies. Among Indonesia\u2019s 26 rabies-endemic provinces, East Nusa Tenggara (NTT) is the most affected, with 19 320 cases of potentially rabid animal bites in humans in 2023. This resulted in 35 rabies deaths. From January to July 2024, NTT reported 16 180 cases of potentially rabid animal bites and 27 rabies deaths.\u00a0 </p><p>\u201cCommunities in rabies-affected provinces must be empowered with both knowledge of and access to life-saving interventions,\u201d said Dr N. Paranietharan, WHO Representative to Indonesia. \u201cSince the beginning of 2023, almost 4 out of 5 Indonesians who died from rabies had not sought medical care after being bitten, simply because they were unaware of the need to do so. This must be addressed \u2013 urgently, decisively, and comprehensively.\u201d</p><p>Any person bitten by a dog should:</p><ul><li>Immediately wash the wound with water and soap or detergent. If water and soap or detergent are unavailable, alcohol can also be effective.</li><li>Fifteen minutes after washing the wound, apply an iodine-containing or anti-viral medication, if available.</li><li>Seek treatment as soon as possible from a healthcare professional and complete all doses of rabies vaccine.</li></ul><li>Immediately wash the wound with water and soap or detergent. If water and soap or detergent are unavailable, alcohol can also be effective.</li><li>Fifteen minutes after washing the wound, apply an iodine-containing or anti-viral medication, if available.</li><li>Seek treatment as soon as possible from a healthcare professional and complete all doses of rabies vaccine.</li><p>Across rabies-endemic provinces, WHO will continue to support the Ministry of Health to increase awareness of personal protective and first-aid measures, improve health worker capacity in bite case management, and enhance access to health facilities equipped with anti-rabies vaccine. </p><p>In 2024, WHO has supported bite case management training for health workers in Pontianak, West Kalimantan and is currently developing a social and behaviour change campaign in NTT specifically.</p><p>However, to prevent and eliminate dog-mediated rabies in people, mass dog vaccination \u2013 supported by effective dog population management \u2013 is the most cost-effective and efficient strategy. Globally, it has been shown that control of canine rabies can be achieved with sustained dog vaccination coverage of 70%.\u00a0</p><p>\u201cIndonesia is making progress towards rabies elimination. To further accelerate this effort, FAO is supporting the Government of Indonesia to develop a strategic operational plan for rabies elimination in Java, Bali, West Nusa Tenggara and NTT,\u201d said Rajendra Aryal, FAO Representative for Indonesia and Timor-Leste.</p><p>One of the key strategies being piloted in these areas is oral rabies vaccination, which targets free-roaming dogs. This complements traditional mass dog vaccination programmes and aims to address challenges in reaching these dog populations. \u201cFAO remains committed to supporting Indonesia's rabies control efforts,\u201d added Aryal.</p><p>WHO and FAO will continue to support Indonesia to end human rabies deaths by 2030, in alignment with the global \u201cZero by 30\u201d strategy, which targets both animal and human health sectors. </p><p>By implementing the strategy, affected countries will move closer to achieving Sustainable Development Goal (SDG) 3.3, \u201cBy 2030, end the epidemics of neglected tropical diseases\u201d, and make progress towards meeting SDG 3.8 on achieving universal health coverage.<strong></strong></p><strong></strong><p><strong>\u00a0</strong></p><strong>\u00a0</strong>"
    },
    {
        "link": "https://www.who.int/indonesia/news/detail/03-09-2024-evaluation-of-ran-pra-2020-2024--control-of-antimicrobial-resistance-achieves-positive-results",
        "date": "3 September 2024",
        "title": "Evaluation of RAN PRA 2020-2024: Control of Antimicrobial Resistance Achieves Positive Results",
        "thumbnail": "https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/amr-nap-monev-1.tmb-768v.png?Culture=en&sfvrsn=b0dbd8a6_2",
        "content": "<div><p>Jakarta, September 3, 2024 - The growing problem of Antimicrobial Resistance (AMR) poses a significant threat to public and animal health. AMR causes higher medical costs and jeopardizes national goals for disease control and food security.</p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">In response, the Indonesian government has established a national policy for controlling AMR through the Regulation of the Coordinating Ministry for Human Development and Culture No. 7/2021, which discusses the National Action Plan for Controlling Antimicrobial Resistance (RAN PRA) 2020-2024 by adopting the One Health approach. The Coordinating Ministry for Human Development and Culture (Kemenko PMK) released the results of the Monitoring and Evaluation (M&amp;E) of RAN PRA 2020-2024, in Jakarta, on Tuesday (3/9/2024).</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">This comprehensive M&amp;E process has been implemented in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and with support from the European Union (EU), through a series of meetings with the AMR control task force working group involving various ministries and institutions.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Acting Deputy for Coordination of Health Quality Improvement and Population Development, Coordinating Ministry for Human Development and Culture, R. Nunung Nuryartono, stated that the implementation of the RAN PRA so far has achieved positive results in the majority of target indicators in efforts to control AMR. \"This shows Indonesia's significant and ongoing efforts in dealing with AMR in the human health, animal health, and environmental sectors through the One Health approach,\" said Nunung.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">According to Deputy Nunung, this achievement is very meaningful considering the complex challenges in achieving sustainable and comprehensive AMR control. \"These results need to be improved again, especially in controlling AMR in the health sector. In general, the implementation of the 2020-2024 RAN PRA has reflected Indonesia's strong commitment to improving AMR control through mitigation measures against the risk of AMR dangers in the future,\" said Nunung.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">The Director General of Animal Husbandry and Animal Health, Ministry of Agriculture, who in this case was represented by the Director of Animal Health, Imron Suandy, highlighted the vital role of animal health in the AMR control strategy through the One Health approach. \"Progress in dealing with AMR in animal health is evidence of our caring efforts in protecting the community in a sustainable manner. Through the implementation of strict regulations and policies, with the support of the private sector, both in the veterinary medicine industry and the commercial poultry industry, we can accelerate the prevention of the spread of AMR from animals,\" said Imron.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Imron explained that he witnessed how the impact of the Antibiotic Growth Promoter (AGP) &amp; colistin ban regulation in commercial poultry farms, had an impact on reducing resistance and levels of extended-spectrum beta-lactamases (ESBL) or enzymes that cause bacteria to become resistant to antibacterial drugs (antibiotics) in farms. This is supported by the industry's awareness to always improve practices, especially in terms of reducing the use of antimicrobials for prophylaxis and increasing the implementation of biosecurity to prevent infections. \"This progress shows our commitment to effective AMR control and highlights the success of our comprehensive strategy within the One Health framework,\" added Imron.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Director General of Health Services, Ministry of Health, Dr. Azhar Jaya, acknowledged the progress and challenges of AMR control in the human health sector. \"Although we have made some progress in controlling AMR, these results show several key areas that require more focused attention. The reduction in ESBL cases and rational use of antimicrobials in health facilities have not reached our targets. We are committed to addressing these challenges through the newly launched National Strategy for AMR Control for the human health sector, which will form the basis for our next cross-sectoral National Action Plan. By strengthening collaboration with various stakeholders, we aim to significantly improve AMR control in Indonesia,\" said Azhar.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">FAO Representative in Indonesia and Timor-Leste, Rajendra Aryal, commended Indonesia's steadfast commitment to combating AMR in a sustainable manner. \"These promising results reflect the effectiveness of a collaborative approach within the One Health framework and underscore the critical role of continued engagement of all relevant stakeholders in advancing AMR control. FAO is pleased to support this effort and celebrate the country's progress towards a safer and healthier future through proactive AMR management,\" said Aryal.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">WHO Representative to Indonesia, Dr. N. Paranietharan, highlighted that the newly launched National Strategy for AMR Control for the human health sector will strengthen the One Health approach. \u201cThis strategy reinforces Indonesia\u2019s commitment to a collaborative approach, which is essential for us to effectively address the global threat of AMR. WHO appreciates Indonesia\u2019s leadership, and will continue to be dedicated in supporting this collective effort,\u201d Paranietharan said.</span><br/></p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">The meeting also emphasized key actions by all stakeholders, including strengthening national surveillance and sharing of AMR data, scaling up AMR control from the central to local levels with clear guidelines, and integrating AMR control into national development plans to promote effective control measures.</span><br/></p></div><p>Jakarta, September 3, 2024 - The growing problem of Antimicrobial Resistance (AMR) poses a significant threat to public and animal health. AMR causes higher medical costs and jeopardizes national goals for disease control and food security.</p><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">In response, the Indonesian government has established a national policy for controlling AMR through the Regulation of the Coordinating Ministry for Human Development and Culture No. 7/2021, which discusses the National Action Plan for Controlling Antimicrobial Resistance (RAN PRA) 2020-2024 by adopting the One Health approach. The Coordinating Ministry for Human Development and Culture (Kemenko PMK) released the results of the Monitoring and Evaluation (M&amp;E) of RAN PRA 2020-2024, in Jakarta, on Tuesday (3/9/2024).</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">In response, the Indonesian government has established a national policy for controlling AMR through the Regulation of the Coordinating Ministry for Human Development and Culture No. 7/2021, which discusses the National Action Plan for Controlling Antimicrobial Resistance (RAN PRA) 2020-2024 by adopting the One Health approach. The Coordinating Ministry for Human Development and Culture (Kemenko PMK) released the results of the Monitoring and Evaluation (M&amp;E) of RAN PRA 2020-2024, in Jakarta, on Tuesday (3/9/2024).</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">This comprehensive M&amp;E process has been implemented in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and with support from the European Union (EU), through a series of meetings with the AMR control task force working group involving various ministries and institutions.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">This comprehensive M&amp;E process has been implemented in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and with support from the European Union (EU), through a series of meetings with the AMR control task force working group involving various ministries and institutions.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Acting Deputy for Coordination of Health Quality Improvement and Population Development, Coordinating Ministry for Human Development and Culture, R. Nunung Nuryartono, stated that the implementation of the RAN PRA so far has achieved positive results in the majority of target indicators in efforts to control AMR. \"This shows Indonesia's significant and ongoing efforts in dealing with AMR in the human health, animal health, and environmental sectors through the One Health approach,\" said Nunung.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Acting Deputy for Coordination of Health Quality Improvement and Population Development, Coordinating Ministry for Human Development and Culture, R. Nunung Nuryartono, stated that the implementation of the RAN PRA so far has achieved positive results in the majority of target indicators in efforts to control AMR. \"This shows Indonesia's significant and ongoing efforts in dealing with AMR in the human health, animal health, and environmental sectors through the One Health approach,\" said Nunung.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">According to Deputy Nunung, this achievement is very meaningful considering the complex challenges in achieving sustainable and comprehensive AMR control. \"These results need to be improved again, especially in controlling AMR in the health sector. In general, the implementation of the 2020-2024 RAN PRA has reflected Indonesia's strong commitment to improving AMR control through mitigation measures against the risk of AMR dangers in the future,\" said Nunung.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">According to Deputy Nunung, this achievement is very meaningful considering the complex challenges in achieving sustainable and comprehensive AMR control. \"These results need to be improved again, especially in controlling AMR in the health sector. In general, the implementation of the 2020-2024 RAN PRA has reflected Indonesia's strong commitment to improving AMR control through mitigation measures against the risk of AMR dangers in the future,\" said Nunung.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">The Director General of Animal Husbandry and Animal Health, Ministry of Agriculture, who in this case was represented by the Director of Animal Health, Imron Suandy, highlighted the vital role of animal health in the AMR control strategy through the One Health approach. \"Progress in dealing with AMR in animal health is evidence of our caring efforts in protecting the community in a sustainable manner. Through the implementation of strict regulations and policies, with the support of the private sector, both in the veterinary medicine industry and the commercial poultry industry, we can accelerate the prevention of the spread of AMR from animals,\" said Imron.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">The Director General of Animal Husbandry and Animal Health, Ministry of Agriculture, who in this case was represented by the Director of Animal Health, Imron Suandy, highlighted the vital role of animal health in the AMR control strategy through the One Health approach. \"Progress in dealing with AMR in animal health is evidence of our caring efforts in protecting the community in a sustainable manner. Through the implementation of strict regulations and policies, with the support of the private sector, both in the veterinary medicine industry and the commercial poultry industry, we can accelerate the prevention of the spread of AMR from animals,\" said Imron.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Imron explained that he witnessed how the impact of the Antibiotic Growth Promoter (AGP) &amp; colistin ban regulation in commercial poultry farms, had an impact on reducing resistance and levels of extended-spectrum beta-lactamases (ESBL) or enzymes that cause bacteria to become resistant to antibacterial drugs (antibiotics) in farms. This is supported by the industry's awareness to always improve practices, especially in terms of reducing the use of antimicrobials for prophylaxis and increasing the implementation of biosecurity to prevent infections. \"This progress shows our commitment to effective AMR control and highlights the success of our comprehensive strategy within the One Health framework,\" added Imron.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Imron explained that he witnessed how the impact of the Antibiotic Growth Promoter (AGP) &amp; colistin ban regulation in commercial poultry farms, had an impact on reducing resistance and levels of extended-spectrum beta-lactamases (ESBL) or enzymes that cause bacteria to become resistant to antibacterial drugs (antibiotics) in farms. This is supported by the industry's awareness to always improve practices, especially in terms of reducing the use of antimicrobials for prophylaxis and increasing the implementation of biosecurity to prevent infections. \"This progress shows our commitment to effective AMR control and highlights the success of our comprehensive strategy within the One Health framework,\" added Imron.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Director General of Health Services, Ministry of Health, Dr. Azhar Jaya, acknowledged the progress and challenges of AMR control in the human health sector. \"Although we have made some progress in controlling AMR, these results show several key areas that require more focused attention. The reduction in ESBL cases and rational use of antimicrobials in health facilities have not reached our targets. We are committed to addressing these challenges through the newly launched National Strategy for AMR Control for the human health sector, which will form the basis for our next cross-sectoral National Action Plan. By strengthening collaboration with various stakeholders, we aim to significantly improve AMR control in Indonesia,\" said Azhar.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">Director General of Health Services, Ministry of Health, Dr. Azhar Jaya, acknowledged the progress and challenges of AMR control in the human health sector. \"Although we have made some progress in controlling AMR, these results show several key areas that require more focused attention. The reduction in ESBL cases and rational use of antimicrobials in health facilities have not reached our targets. We are committed to addressing these challenges through the newly launched National Strategy for AMR Control for the human health sector, which will form the basis for our next cross-sectoral National Action Plan. By strengthening collaboration with various stakeholders, we aim to significantly improve AMR control in Indonesia,\" said Azhar.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">FAO Representative in Indonesia and Timor-Leste, Rajendra Aryal, commended Indonesia's steadfast commitment to combating AMR in a sustainable manner. \"These promising results reflect the effectiveness of a collaborative approach within the One Health framework and underscore the critical role of continued engagement of all relevant stakeholders in advancing AMR control. FAO is pleased to support this effort and celebrate the country's progress towards a safer and healthier future through proactive AMR management,\" said Aryal.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">FAO Representative in Indonesia and Timor-Leste, Rajendra Aryal, commended Indonesia's steadfast commitment to combating AMR in a sustainable manner. \"These promising results reflect the effectiveness of a collaborative approach within the One Health framework and underscore the critical role of continued engagement of all relevant stakeholders in advancing AMR control. FAO is pleased to support this effort and celebrate the country's progress towards a safer and healthier future through proactive AMR management,\" said Aryal.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">WHO Representative to Indonesia, Dr. N. Paranietharan, highlighted that the newly launched National Strategy for AMR Control for the human health sector will strengthen the One Health approach. \u201cThis strategy reinforces Indonesia\u2019s commitment to a collaborative approach, which is essential for us to effectively address the global threat of AMR. WHO appreciates Indonesia\u2019s leadership, and will continue to be dedicated in supporting this collective effort,\u201d Paranietharan said.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">WHO Representative to Indonesia, Dr. N. Paranietharan, highlighted that the newly launched National Strategy for AMR Control for the human health sector will strengthen the One Health approach. \u201cThis strategy reinforces Indonesia\u2019s commitment to a collaborative approach, which is essential for us to effectively address the global threat of AMR. WHO appreciates Indonesia\u2019s leadership, and will continue to be dedicated in supporting this collective effort,\u201d Paranietharan said.</span><br/><p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">The meeting also emphasized key actions by all stakeholders, including strengthening national surveillance and sharing of AMR data, scaling up AMR control from the central to local levels with clear guidelines, and integrating AMR control into national development plans to promote effective control measures.</span><br/></p><span style=\"background-color:transparent;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\">The meeting also emphasized key actions by all stakeholders, including strengthening national surveillance and sharing of AMR data, scaling up AMR control from the central to local levels with clear guidelines, and integrating AMR control into national development plans to promote effective control measures.</span><br/>"
    },
    {
        "link": "https://www.who.int/indonesia/news/feature-stories/detail/a-second-chance-at-health--agus-s-battle-with-hepatitis-c-in-a-correctional-facility",
        "date": "14 October 2024",
        "title": "A second chance at health: Agus's battle with hepatitis C in a correctional facility",
        "thumbnail": "https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/20241001-agus-cover.tmb-768v.jpeg?Culture=en&sfvrsn=366fb651_2",
        "content": "<div><p>In Narcotics Penitentiary Class IIA Jakarta, 45-year-old Agus found an unexpected path to healing. Like others serving time, he was unaware of the silent threat lurking inside him until a routine medical test changed his life.</p><p>\"I didn't know I had hepatitis,\" Agus recalls. \u201cI only noticed pain when I slept on my right side.\u201d This small discomfort was a sign of something much more serious.</p><p align=\"center\" style=\"text-align:center;\"><img alt=\"An adult man extends his hand to a healthcare worker for hepatitis C screening.\" sf-size=\"482892\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/20241001-agus1.png?sfvrsn=f2517f56_5\"/></p><p align=\"center\" style=\"text-align:center;\"><em>Agus being screened for hepatitis C. Credits: WHO/Bunga Manggiasih</em></p><p>At the facility, Agus was diagnosed with hepatitis C, a virus that if left untreated can cause severe liver problems. The virus spreads through contact with infected blood and is a significant health challenge in correctional facilities worldwide. </p><p>Since 2018, Indonesian authorities have implemented routine hepatitis C screening and treatment in seven correctional facilities. WHO has supported the intervention by developing guidelines and assisting in monitoring and evaluation of implementation. This year, the Government of Indonesia is also developing a National Action Plan for Prevention and Control of Hepatitis in correctional facilities throughout the nation.</p><p>Dr Finnahari, the hepatitis C programme officer at the facility, stresses how important these screenings are. \u00a0\"Early detection is key. This allows us to treat them promptly and prevent the spread of hepatitis C within the facility.\"</p><p>For Agus, this early detection may have saved his life. \"By chance, there was a screening, and my name was called,\" he says. \"When I was tested, it turned out to be positive.\"</p><p>After being diagnosed, Agus was put on a three-month treatment plan right away. The treatment he received is part of a newer, highly effective regimen known as direct-acting antivirals (DAA).</p><p align=\"center\" style=\"text-align:center;\"><img alt=\"A man bends down at the drug counter to get his medicine.\" sf-size=\"424321\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/20241001-agus2.png?sfvrsn=c3307b9a_5\"/></p><p align=\"center\" style=\"text-align:center;\"><em>Healthcare workers in the clinic of Narcotics Penitentiary Class IIA Jakarta provide DAA medication for those diagnosed with hepatitis C. Credits: WHO/Bunga Manggiasih</em></p><p>Dr Alima Susilawati Sadrina, an internist at Pengayoman Hospital, which serves as the referral center for hepatitis C treatment in Jakarta's correctional facilities, explains how effective this treatment is. \"The cure rate of DAA therapy exceeds 95%, consistent with global outcomes. When patients take the medicine regularly, they should recover completely.\u201d</p><p>For Agus, the results were life-changing. \"After taking the medicine for three months and being tested again, the results were negative,\" he says with relief. \"Now my body feels good again. I can sleep on either side without any pain.\"</p><p>The success of Agus's treatment is not an isolated case. Between 2018 and 2023, screenings in several Indonesian correctional facilities identified 1746 individuals infected with hepatitis C, many of whom have since received treatment.</p><p>Agus believes these screenings and treatments should be available in more facilities. \u00a0\"It\u2019s really helpful, especially for those serving long sentences who might not be able to seek treatment outside or afford it. Here, we\u2019re lucky to receive free treatment.\"</p><div><p>Indonesia\u2019s efforts to eliminate hepatitis C in prisons are setting an example for public health programmes the world over. By offering free screenings and treatment, Indonesia is ensuring that even people behind bars have the right to good healthcare. And as more prisons adopt these programmes, more people like Agus will have a chance to recover and live healthier lives, creating a safer, healthier community for everyone.</p>\n<hr/><em>Written by Bunga Manggiasih, </em><em>National Professional Officer (Communication), WHO Indonesia</em>\n</div></div><p>In Narcotics Penitentiary Class IIA Jakarta, 45-year-old Agus found an unexpected path to healing. Like others serving time, he was unaware of the silent threat lurking inside him until a routine medical test changed his life.</p><p>\"I didn't know I had hepatitis,\" Agus recalls. \u201cI only noticed pain when I slept on my right side.\u201d This small discomfort was a sign of something much more serious.</p><p align=\"center\" style=\"text-align:center;\"><img alt=\"An adult man extends his hand to a healthcare worker for hepatitis C screening.\" sf-size=\"482892\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/20241001-agus1.png?sfvrsn=f2517f56_5\"/></p><img alt=\"An adult man extends his hand to a healthcare worker for hepatitis C screening.\" sf-size=\"482892\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/20241001-agus1.png?sfvrsn=f2517f56_5\"/><p align=\"center\" style=\"text-align:center;\"><em>Agus being screened for hepatitis C. Credits: WHO/Bunga Manggiasih</em></p><em>Agus being screened for hepatitis C. Credits: WHO/Bunga Manggiasih</em><p>At the facility, Agus was diagnosed with hepatitis C, a virus that if left untreated can cause severe liver problems. The virus spreads through contact with infected blood and is a significant health challenge in correctional facilities worldwide. </p><p>Since 2018, Indonesian authorities have implemented routine hepatitis C screening and treatment in seven correctional facilities. WHO has supported the intervention by developing guidelines and assisting in monitoring and evaluation of implementation. This year, the Government of Indonesia is also developing a National Action Plan for Prevention and Control of Hepatitis in correctional facilities throughout the nation.</p><p>Dr Finnahari, the hepatitis C programme officer at the facility, stresses how important these screenings are. \u00a0\"Early detection is key. This allows us to treat them promptly and prevent the spread of hepatitis C within the facility.\"</p><p>For Agus, this early detection may have saved his life. \"By chance, there was a screening, and my name was called,\" he says. \"When I was tested, it turned out to be positive.\"</p><p>After being diagnosed, Agus was put on a three-month treatment plan right away. The treatment he received is part of a newer, highly effective regimen known as direct-acting antivirals (DAA).</p><p align=\"center\" style=\"text-align:center;\"><img alt=\"A man bends down at the drug counter to get his medicine.\" sf-size=\"424321\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/20241001-agus2.png?sfvrsn=c3307b9a_5\"/></p><img alt=\"A man bends down at the drug counter to get his medicine.\" sf-size=\"424321\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/20241001-agus2.png?sfvrsn=c3307b9a_5\"/><p align=\"center\" style=\"text-align:center;\"><em>Healthcare workers in the clinic of Narcotics Penitentiary Class IIA Jakarta provide DAA medication for those diagnosed with hepatitis C. Credits: WHO/Bunga Manggiasih</em></p><em>Healthcare workers in the clinic of Narcotics Penitentiary Class IIA Jakarta provide DAA medication for those diagnosed with hepatitis C. Credits: WHO/Bunga Manggiasih</em><p>Dr Alima Susilawati Sadrina, an internist at Pengayoman Hospital, which serves as the referral center for hepatitis C treatment in Jakarta's correctional facilities, explains how effective this treatment is. \"The cure rate of DAA therapy exceeds 95%, consistent with global outcomes. When patients take the medicine regularly, they should recover completely.\u201d</p><p>For Agus, the results were life-changing. \"After taking the medicine for three months and being tested again, the results were negative,\" he says with relief. \"Now my body feels good again. I can sleep on either side without any pain.\"</p><p>The success of Agus's treatment is not an isolated case. Between 2018 and 2023, screenings in several Indonesian correctional facilities identified 1746 individuals infected with hepatitis C, many of whom have since received treatment.</p><p>Agus believes these screenings and treatments should be available in more facilities. \u00a0\"It\u2019s really helpful, especially for those serving long sentences who might not be able to seek treatment outside or afford it. Here, we\u2019re lucky to receive free treatment.\"</p><div><p>Indonesia\u2019s efforts to eliminate hepatitis C in prisons are setting an example for public health programmes the world over. By offering free screenings and treatment, Indonesia is ensuring that even people behind bars have the right to good healthcare. And as more prisons adopt these programmes, more people like Agus will have a chance to recover and live healthier lives, creating a safer, healthier community for everyone.</p>\n<hr/><em>Written by Bunga Manggiasih, </em><em>National Professional Officer (Communication), WHO Indonesia</em>\n</div><p>Indonesia\u2019s efforts to eliminate hepatitis C in prisons are setting an example for public health programmes the world over. By offering free screenings and treatment, Indonesia is ensuring that even people behind bars have the right to good healthcare. And as more prisons adopt these programmes, more people like Agus will have a chance to recover and live healthier lives, creating a safer, healthier community for everyone.</p><hr/><em>Written by Bunga Manggiasih, </em><em>National Professional Officer (Communication), WHO Indonesia</em>"
    },
    {
        "link": "https://www.who.int/indonesia/news/feature-stories/detail/bridging-the-gap--how-training-health-workers-is-key-to-boosting-aceh-s-immunization-coverage",
        "date": "30 September 2024",
        "title": "Bridging the gap: How training health workers is key to boosting Aceh\u2019s immunization coverage",
        "thumbnail": "https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc05076-min.tmb-768v.jpg?Culture=en&sfvrsn=9bbff8cc_1",
        "content": "<div><p>For the past 5 years, midwife-turned-immunization coordinator Nur Khalida has been based at Puskesmas Ingin Jaya, a neat, yellow-washed building in Aceh Besar, on the outskirts of Banda Aceh City.\u00a0\u00a0</p><p>Most days, Nur works with local midwives on how best to improve immunization coverage, focusing on addressing vaccine hesitancy.\u00a0\u00a0</p><p>\"I believe in using a personal approach to build trust with the community,\u201d she explains, adding, \u201cI always offer my phone number for follow-up questions, which helps alleviate fears.\u201d\u202f\u00a0</p><p style=\"text-align:center;\"><img alt=\"A group of women participating in a workshop.\" sf-size=\"1170059\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc05076-min.jpg?sfvrsn=9bbff8cc_3\"/><span style=\"background-color:initial;color:#333333;font-family:inherit;font-size:inherit;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\"><sub>Nur Khalida (left) and other participants engage in a role-play exercise. These practical sessions on immunisation administration and role-playing exercises helped participants effectively explain diseases and vaccinations to parents. (WHO/Fieni Aprilia)\u00a0</sub></span></p><div data-class=\"sf-accordion__panel\"><div data-class=\"sf-accordion__content\"></div></div><p>In Aceh, recent outbreaks of vaccine-preventable diseases such as measles, polio and diphtheria have highlighted the urgent need to improve immunization coverage. In 2023, just 20.8% of children in Aceh were fully immunized, well below the national average of 95.3%.\u00a0\u00a0</p><p>However, as Nur\u2019s experience shows, well-trained and empowered health workers can boost vaccine acceptance, protect communities and ultimately save lives.\u00a0\u00a0</p><p>\u201cHealth workers are the bridge between public health policies and the communities they serve,\u201d explains Dr Muhammad Fathun, WHO Technical Officer for vaccination in Aceh. \u201cIt\u2019s not enough to simply offer vaccines; they must be able to communicate, educate and earn people\u2019s trust.\u201d\u00a0</p><p>This simple yet crucial observation was the foundation of a Ministry of Health (MoH) and World Health Organization (WHO)-supported training in Banda Aceh City, on 18\u201327 June 2024.\u00a0\u00a0</p><p style=\"text-align:center;\"><img alt=\"\" sf-size=\"735371\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc04980-min.jpg?sfvrsn=3096c774_3\"/><span style=\"background-color:initial;color:#333333;font-family:inherit;font-size:inherit;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\"><sup>Trainers demonstrated how to identify frozen vaccines, do the shake test, and how to store them properly. (WHO/Fieni Aprilia)\u00a0</sup></span></p><div data-class=\"sf-accordion__panel\"><div data-class=\"sf-accordion__content\"></div></div><p>\u201cMany people in the community fear adverse events following immunization or face opposition from family members, particularly fathers,\u201d says Dr Fathun. \u201cSo, we addressed these concerns with participants through practical role-playing exercises.\u201d\u00a0\u00a0</p><p>\u201cUltimately, frontline health workers are the ones who have the most direct contact with families, so they need to be equipped with the right tools and communication skills to address community concerns in a compassionate and understanding way.\"\u00a0</p><p>The MoH and WHO-supported training was conducted in two five-day batches, bringing together 180 participants from 7 districts in the province. This included 102 immunization officers and 78 midwives, mostly from puskesmas</p><p>In addition to community engagement and education, the training covered key skills such as microplanning and vaccine cold chain management, including how to identify frozen vaccines.\u00a0\u00a0</p><p style=\"text-align:center;\"><img alt=\"Two women in a health facility carefully checking and organizing vaccine supplies in a cold storage unit.\" sf-size=\"1360492\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc05154-min.jpg?sfvrsn=13ac12d0_3\"/><sup>Participants engage in hands-on record keeping and cold chain management training at a Puskesmas. (WHO/Fieni Aprilia)\u00a0</sup></p><p>Sessions were also held on reporting immunization programme implementation, surveillance of adverse events following immunization, and monitoring and evaluating immunization activities.\u202f\u202f\u00a0</p><p>Nur notes that both the content of the training and the participants marked a significant shift from earlier approaches.\u00a0\u00a0</p><p>Previously, training for central health office staff was prioritized, while training for midwives and immunization officers was minimal.\u00a0\u00a0</p><p>This is despite, Nur says, the immunization officers often knowing who was vaccinated and who was not.\u00a0\u00a0\u00a0</p><p>In Aceh, gaps are being bridged \u2013 one health worker at a time.\u00a0\u00a0\u00a0</p><hr/><p><em>This activity was supported by the Australian government through the Department of Foreign Affairs and Trade.\u202f\u00a0</em><em><br/></em><br/><em>Written by Fieni Aprilia, Digital Communications Officer, WHO Indonesia\u202f\u00a0</em></p></div><p>For the past 5 years, midwife-turned-immunization coordinator Nur Khalida has been based at Puskesmas Ingin Jaya, a neat, yellow-washed building in Aceh Besar, on the outskirts of Banda Aceh City.\u00a0\u00a0</p><p>Most days, Nur works with local midwives on how best to improve immunization coverage, focusing on addressing vaccine hesitancy.\u00a0\u00a0</p><p>\"I believe in using a personal approach to build trust with the community,\u201d she explains, adding, \u201cI always offer my phone number for follow-up questions, which helps alleviate fears.\u201d\u202f\u00a0</p><p style=\"text-align:center;\"><img alt=\"A group of women participating in a workshop.\" sf-size=\"1170059\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc05076-min.jpg?sfvrsn=9bbff8cc_3\"/><span style=\"background-color:initial;color:#333333;font-family:inherit;font-size:inherit;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\"><sub>Nur Khalida (left) and other participants engage in a role-play exercise. These practical sessions on immunisation administration and role-playing exercises helped participants effectively explain diseases and vaccinations to parents. (WHO/Fieni Aprilia)\u00a0</sub></span></p><img alt=\"A group of women participating in a workshop.\" sf-size=\"1170059\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc05076-min.jpg?sfvrsn=9bbff8cc_3\"/><span style=\"background-color:initial;color:#333333;font-family:inherit;font-size:inherit;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\"><sub>Nur Khalida (left) and other participants engage in a role-play exercise. These practical sessions on immunisation administration and role-playing exercises helped participants effectively explain diseases and vaccinations to parents. (WHO/Fieni Aprilia)\u00a0</sub></span><sub>Nur Khalida (left) and other participants engage in a role-play exercise. These practical sessions on immunisation administration and role-playing exercises helped participants effectively explain diseases and vaccinations to parents. (WHO/Fieni Aprilia)\u00a0</sub><div data-class=\"sf-accordion__panel\"><div data-class=\"sf-accordion__content\"></div></div><div data-class=\"sf-accordion__content\"></div><p>In Aceh, recent outbreaks of vaccine-preventable diseases such as measles, polio and diphtheria have highlighted the urgent need to improve immunization coverage. In 2023, just 20.8% of children in Aceh were fully immunized, well below the national average of 95.3%.\u00a0\u00a0</p><p>However, as Nur\u2019s experience shows, well-trained and empowered health workers can boost vaccine acceptance, protect communities and ultimately save lives.\u00a0\u00a0</p><p>\u201cHealth workers are the bridge between public health policies and the communities they serve,\u201d explains Dr Muhammad Fathun, WHO Technical Officer for vaccination in Aceh. \u201cIt\u2019s not enough to simply offer vaccines; they must be able to communicate, educate and earn people\u2019s trust.\u201d\u00a0</p><p>This simple yet crucial observation was the foundation of a Ministry of Health (MoH) and World Health Organization (WHO)-supported training in Banda Aceh City, on 18\u201327 June 2024.\u00a0\u00a0</p><p style=\"text-align:center;\"><img alt=\"\" sf-size=\"735371\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc04980-min.jpg?sfvrsn=3096c774_3\"/><span style=\"background-color:initial;color:#333333;font-family:inherit;font-size:inherit;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\"><sup>Trainers demonstrated how to identify frozen vaccines, do the shake test, and how to store them properly. (WHO/Fieni Aprilia)\u00a0</sup></span></p><img alt=\"\" sf-size=\"735371\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc04980-min.jpg?sfvrsn=3096c774_3\"/><span style=\"background-color:initial;color:#333333;font-family:inherit;font-size:inherit;text-align:inherit;text-transform:inherit;word-spacing:normal;caret-color:auto;white-space:inherit;\"><sup>Trainers demonstrated how to identify frozen vaccines, do the shake test, and how to store them properly. (WHO/Fieni Aprilia)\u00a0</sup></span><sup>Trainers demonstrated how to identify frozen vaccines, do the shake test, and how to store them properly. (WHO/Fieni Aprilia)\u00a0</sup><div data-class=\"sf-accordion__panel\"><div data-class=\"sf-accordion__content\"></div></div><div data-class=\"sf-accordion__content\"></div><p>\u201cMany people in the community fear adverse events following immunization or face opposition from family members, particularly fathers,\u201d says Dr Fathun. \u201cSo, we addressed these concerns with participants through practical role-playing exercises.\u201d\u00a0\u00a0</p><p>\u201cUltimately, frontline health workers are the ones who have the most direct contact with families, so they need to be equipped with the right tools and communication skills to address community concerns in a compassionate and understanding way.\"\u00a0</p><p>The MoH and WHO-supported training was conducted in two five-day batches, bringing together 180 participants from 7 districts in the province. This included 102 immunization officers and 78 midwives, mostly from puskesmas</p><p>In addition to community engagement and education, the training covered key skills such as microplanning and vaccine cold chain management, including how to identify frozen vaccines.\u00a0\u00a0</p><p style=\"text-align:center;\"><img alt=\"Two women in a health facility carefully checking and organizing vaccine supplies in a cold storage unit.\" sf-size=\"1360492\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc05154-min.jpg?sfvrsn=13ac12d0_3\"/><sup>Participants engage in hands-on record keeping and cold chain management training at a Puskesmas. (WHO/Fieni Aprilia)\u00a0</sup></p><img alt=\"Two women in a health facility carefully checking and organizing vaccine supplies in a cold storage unit.\" sf-size=\"1360492\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc05154-min.jpg?sfvrsn=13ac12d0_3\"/><sup>Participants engage in hands-on record keeping and cold chain management training at a Puskesmas. (WHO/Fieni Aprilia)\u00a0</sup><p>Sessions were also held on reporting immunization programme implementation, surveillance of adverse events following immunization, and monitoring and evaluating immunization activities.\u202f\u202f\u00a0</p><p>Nur notes that both the content of the training and the participants marked a significant shift from earlier approaches.\u00a0\u00a0</p><p>Previously, training for central health office staff was prioritized, while training for midwives and immunization officers was minimal.\u00a0\u00a0</p><p>This is despite, Nur says, the immunization officers often knowing who was vaccinated and who was not.\u00a0\u00a0\u00a0</p><p>In Aceh, gaps are being bridged \u2013 one health worker at a time.\u00a0\u00a0\u00a0</p><hr/><p><em>This activity was supported by the Australian government through the Department of Foreign Affairs and Trade.\u202f\u00a0</em><em><br/></em><br/><em>Written by Fieni Aprilia, Digital Communications Officer, WHO Indonesia\u202f\u00a0</em></p><em>This activity was supported by the Australian government through the Department of Foreign Affairs and Trade.\u202f\u00a0</em><em><br/></em><br/><br/><em>Written by Fieni Aprilia, Digital Communications Officer, WHO Indonesia\u202f\u00a0</em>"
    },
    {
        "link": "https://www.who.int/indonesia/news/feature-stories/detail/protecting-children-across-borders--how-polio-vaccination-in-indonesia-also-shields-children-in-papua-new-guinea",
        "date": "7 August 2024",
        "title": "Protecting children across borders: How polio vaccination in Indonesia also shields children in Papua New Guinea",
        "thumbnail": "https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/dokter_samuel_cover.tmb-768v.jpg?Culture=en&sfvrsn=4ded55c4_2",
        "content": "<div><p>In the bustling border town of Jayapura, Papua Province, Dr Samuel J. Kambuaya and his team at the Skouw Primary Health Care Center (Puskesmas) are making waves in the fight against polio. Their efforts not only protect Indonesian children but also extend a shield of immunity to those in neighbouring Papua New Guinea (PNG).</p><p>The urgency of their mission is clear. With complete polio vaccination rates in Papua Province as low as 44.42% in 2023, reaching the target of 95% coverage for children aged 0-7 years seemed daunting. Recent polio outbreaks in neighbouring provinces of Greater Papua have raised alarm in both Indonesia and PNG. With WHO\u2019s assistance, Dr Samuel's team rose to the challenge, implementing innovative strategies that have had far-reaching impact.</p><p>\u201cWe used to wait for people to come to the Puskesmas,\u201d Dr Samuel explains. \u201cBut many families struggle with transportation costs. Now, with WHO assistance, we actively go into the villages. Our vaccination coverage showed substantial growth afterward.\u201d</p><p><img alt=\"A group of students in uniforms gathered around health care workers who are preparing for polio vaccination\" class=\"-align-center\" sf-size=\"444962\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/dokter_samuel_school.jpg?sfvrsn=48f774db_7\" style=\"display:block;margin-left:auto;margin-right:auto;\"/></p><p style=\"text-align:center;\"><em>Dr Samuel J. Kambuaya and Nurse Biuti Mawar Sari checked the students list as they prepared to administer the nOPV2 polio vaccine in Skouw village, Jayapura City, Papua, on 22 July 2024.</em></p><p>On 27 May 2024, only 46 children were vaccinated, which is 13% of the 347 children who should receive this protection from Puskesmas Skouw team in the first round of the 2024 polio campaign. Support from WHO helped enable the Puskesmas to vaccinate 442 children by the end of the campaign on 21 June 2024, well above the targeted coverage.</p><p>The team conducts its work in key areas around the Cross-Border Post (PLBN) Skouw RI-PNG. On average, 100 people pass through the border post daily, with numbers rising to approximately 1000 on Saturdays, when the nearby market is open for trade. These locations, where communities exist across national boundaries, have become central to the team's efforts.</p><p>\"We realized that many families in our area have roots on both sides of the border,\" Dr Samuel says. \"Children often cross back and forth with their parents. By vaccinating these mobile populations, we're not just protecting Indonesian children, but also creating a buffer of immunity that extends into PNG.\"</p><p>WHO's assistance has been crucial in enhancing the skills of healthcare workers to implement the polio campaign and address cross-border challenges. This has enabled Dr Samuel's team to vaccinate children who might have otherwise been overlooked.</p><p><img alt=\"A person carrying a vaccine carrier box walking towards the Cross-Border Post Skouw of Indonesia-Papua New Guinea\" sf-size=\"406123\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/dokter_samuel_border.jpg?sfvrsn=e697657f_5\"/></p><p style=\"text-align:center;\"><em>Dr Samuel walks towards the border post of the Republic of Indonesia and Papua New Guinea in Skouw, Jayapura City, Papua. Credits: WHO/Rosa Panggabean</em></p><p>As the campaign continues, Dr Samuel remains committed to this broader vision of public health. \"Every child we vaccinate here could prevent an outbreak there,\" he says, pointing towards the PNG border. \"We're not just fighting polio in Indonesia; we're contributing to the global eradication effort.\"</p><p>His team stands ready to vaccinate children from PNG if they are present in the Skouw area, in alignment with National immunization guidelines. The guidelines stipulate that all children encountered during vaccination activities are eligible to receive immunization, regardless of their country of origin.</p><p>In this corner of the world, where borders are fluid and communities interconnected, Dr Samuel and his team are building a healthier future for children on both sides of the border, one vaccine at a time.</p><hr/>This activity is supported by the US Government through USAID.<p><em>Written by Olivi Silalahi, National Professional Officer of Routine Immunization, WHO Indonesia.</em><em></em></p><p>\u00a0</p></div><p>In the bustling border town of Jayapura, Papua Province, Dr Samuel J. Kambuaya and his team at the Skouw Primary Health Care Center (Puskesmas) are making waves in the fight against polio. Their efforts not only protect Indonesian children but also extend a shield of immunity to those in neighbouring Papua New Guinea (PNG).</p><p>The urgency of their mission is clear. With complete polio vaccination rates in Papua Province as low as 44.42% in 2023, reaching the target of 95% coverage for children aged 0-7 years seemed daunting. Recent polio outbreaks in neighbouring provinces of Greater Papua have raised alarm in both Indonesia and PNG. With WHO\u2019s assistance, Dr Samuel's team rose to the challenge, implementing innovative strategies that have had far-reaching impact.</p><p>\u201cWe used to wait for people to come to the Puskesmas,\u201d Dr Samuel explains. \u201cBut many families struggle with transportation costs. Now, with WHO assistance, we actively go into the villages. Our vaccination coverage showed substantial growth afterward.\u201d</p><p><img alt=\"A group of students in uniforms gathered around health care workers who are preparing for polio vaccination\" class=\"-align-center\" sf-size=\"444962\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/dokter_samuel_school.jpg?sfvrsn=48f774db_7\" style=\"display:block;margin-left:auto;margin-right:auto;\"/></p><img alt=\"A group of students in uniforms gathered around health care workers who are preparing for polio vaccination\" class=\"-align-center\" sf-size=\"444962\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/dokter_samuel_school.jpg?sfvrsn=48f774db_7\" style=\"display:block;margin-left:auto;margin-right:auto;\"/><p style=\"text-align:center;\"><em>Dr Samuel J. Kambuaya and Nurse Biuti Mawar Sari checked the students list as they prepared to administer the nOPV2 polio vaccine in Skouw village, Jayapura City, Papua, on 22 July 2024.</em></p><em>Dr Samuel J. Kambuaya and Nurse Biuti Mawar Sari checked the students list as they prepared to administer the nOPV2 polio vaccine in Skouw village, Jayapura City, Papua, on 22 July 2024.</em><p>On 27 May 2024, only 46 children were vaccinated, which is 13% of the 347 children who should receive this protection from Puskesmas Skouw team in the first round of the 2024 polio campaign. Support from WHO helped enable the Puskesmas to vaccinate 442 children by the end of the campaign on 21 June 2024, well above the targeted coverage.</p><p>The team conducts its work in key areas around the Cross-Border Post (PLBN) Skouw RI-PNG. On average, 100 people pass through the border post daily, with numbers rising to approximately 1000 on Saturdays, when the nearby market is open for trade. These locations, where communities exist across national boundaries, have become central to the team's efforts.</p><p>\"We realized that many families in our area have roots on both sides of the border,\" Dr Samuel says. \"Children often cross back and forth with their parents. By vaccinating these mobile populations, we're not just protecting Indonesian children, but also creating a buffer of immunity that extends into PNG.\"</p><p>WHO's assistance has been crucial in enhancing the skills of healthcare workers to implement the polio campaign and address cross-border challenges. This has enabled Dr Samuel's team to vaccinate children who might have otherwise been overlooked.</p><p><img alt=\"A person carrying a vaccine carrier box walking towards the Cross-Border Post Skouw of Indonesia-Papua New Guinea\" sf-size=\"406123\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/dokter_samuel_border.jpg?sfvrsn=e697657f_5\"/></p><img alt=\"A person carrying a vaccine carrier box walking towards the Cross-Border Post Skouw of Indonesia-Papua New Guinea\" sf-size=\"406123\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/photos/dokter_samuel_border.jpg?sfvrsn=e697657f_5\"/><p style=\"text-align:center;\"><em>Dr Samuel walks towards the border post of the Republic of Indonesia and Papua New Guinea in Skouw, Jayapura City, Papua. Credits: WHO/Rosa Panggabean</em></p><em>Dr Samuel walks towards the border post of the Republic of Indonesia and Papua New Guinea in Skouw, Jayapura City, Papua. Credits: WHO/Rosa Panggabean</em><p>As the campaign continues, Dr Samuel remains committed to this broader vision of public health. \"Every child we vaccinate here could prevent an outbreak there,\" he says, pointing towards the PNG border. \"We're not just fighting polio in Indonesia; we're contributing to the global eradication effort.\"</p><p>His team stands ready to vaccinate children from PNG if they are present in the Skouw area, in alignment with National immunization guidelines. The guidelines stipulate that all children encountered during vaccination activities are eligible to receive immunization, regardless of their country of origin.</p><p>In this corner of the world, where borders are fluid and communities interconnected, Dr Samuel and his team are building a healthier future for children on both sides of the border, one vaccine at a time.</p><hr/><p><em>Written by Olivi Silalahi, National Professional Officer of Routine Immunization, WHO Indonesia.</em><em></em></p><em>Written by Olivi Silalahi, National Professional Officer of Routine Immunization, WHO Indonesia.</em><em></em><p>\u00a0</p>"
    },
    {
        "link": "https://www.who.int/indonesia/news/feature-stories/detail/turning-the-tide--protecting-coastal-communities-from-infectious-diseases",
        "date": "26 April 2024",
        "title": "Turning the tide: protecting coastal communities from infectious diseases",
        "thumbnail": "https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03373-2.tmb-768v.jpg?Culture=en&sfvrsn=b4bdda92_2",
        "content": "<div><p><p>On a humid and rainy afternoon in Demak District, Central Java health professional Dr Lisa Novipuspitasari looks out from her clinic and recalls the number of times that floods swallowed roads, landmarks and even entire villages. </p><p>The coastal community she serves is familiar with the ferocity of water. Heavy rains coupled with rising tides and coastal erosion make the area prone not just to flooding but the diseases it brings. \u00a0</p><p>\u201cToday I attended to another suspected leptospirosis patient in the emergency unit,\u201d she shares with concern. \u201cJust last night, we escalated another case from observation in emergency care to inpatient treatment,\u201d she adds. </p><p>Year after year, Dr Lisa has been at the forefront of the fight against leptospirosis, a zoonotic and climate-sensitive disease that can result in mild illness that may progress to a serious and sometimes fatal disease. </p><p>She is one of just a few leptospirosis specialists in Demak, treating patients with symptoms ranging from flu-like illness to kidney failure and Severe Pulmonary Hemorrhagic Syndrome.</p><p><img alt=\"A person wearing a magenta dress and patterned shawl stands in an office setting with the text \" sf-size=\"489719\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03105-2.jpg?sfvrsn=fa955730_3\"/></p><p style=\"text-align:center;\">Dr Lisa standing in front of the RSUD Sultanfatah sign. As one of just a few leptospirosis specialists, she is leading efforts to prevent and control leptospirosis infections. (WHO/Fieni Aprilia)</p><p>\u201cAt first, Leptospirosis barely registered as a concern, even among health professionals,\u201d she explains, adding that as the annual death toll rose, she studied how best to treat it, guided by her academic advisor, Professor Gasem, and with insights obtained from research by the National Research and Innovation Agency. </p><p>\u201cToo often, leptospirosis is misdiagnosed as dengue or typhoid, leading to tragic outcomes when diagnosed and treated too late,\u201d she says ruefully. \u00a0</p><p>Over the past year, however, the tide has started to turn. Since January 2023, World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), USAID-IDDS and the Indonesian Ministry of Health and local government have joined forces to strengthen leptospirosis prevention and control in Demak, which is expected to face rising sea levels and land subsidence of two to eight centimeters per year.</p><p><img alt=\"A patient lying in a hospital bed with medical equipment and a relative standing by their side.\" sf-size=\"434752\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03091-2.jpg?sfvrsn=8048959b_3\"/></p><p style=\"text-align:center;\">A leptospirosis patient undergoing treatment in Demak. As a result of advocacy efforts, the Puskesmas is better prepared and capable of reducing deaths due to leptospirosis. (WHO/Fieni Aprilia)</p><p>Thus far, health and cross-sectoral partners such as the Coordinating Ministry on Human Development and Culture and the Ministry of Agriculture have conducted a joint risk assessment for leptospirosis, developed a series of actionable recommendations to enhance preventive measures, and also established a local zoonosis and emerging infectious disease coordination team, in alignment with the \u201cOne Health\u201d approach, which recognizes the interconnectedness of animal, human and environmental health.</p><p>According to Dr Lisa, these and other initiatives have helped strengthen leptospirosis surveillance and case detection, enhance environmental management and increase rodent trapping, knowledge and awareness-sharing among health workers and the public. </p><p>Lead rodent trapper Amin Sukron agrees. In Bonang village, Amin supervises rodent trapping activities in the homes of leptospirosis survivors, using funds from the village. He has long recognized the correlation between leptospirosis cases and flood-prone areas, where rodents that spread leptospirosis breed. \u00a0</p><p><img alt=\"A person wearing a batik shirt with a name tag reading 'AMIN SURKON' stands in front of a green gate and wall.\" sf-size=\"726871\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03188-2.jpg?sfvrsn=acd3dbaa_3\"/></p><p style=\"text-align:center;\">Amin Sukron, one of the rodent cadres in Bonang Village. (WHO/Fieni Aprilia)</p><p>Amin says that knowledge obtained from Dr Lisa and other health workers at Bonang I Puskesmas has been crucial to strengthening preventive measures, which are most effective when multiple activities are conducted concurrently, with close communication between key actors and the public. </p><p>For this, the One Health approach will continue to be central to WHO, FAO, USAID-IDDS and Ministry of Health and local government efforts. From her clinic in Demak, Dr Lisa reflects positively on the downward trend in leptospirosis cases, in both incidence and severity \u2013 testament, she says, to the collective efforts of partners and the community to protect health and well-being from infectious diseases and the health impacts of climate change.\u00a0\u00a0</p><hr/><p>This activity is supported by the U.S. Government through USAID. <br/><em>Written by Ayunita Mahdy, reporting and documentation officer, WHO Indonesia</em></p></p></div><p><p>On a humid and rainy afternoon in Demak District, Central Java health professional Dr Lisa Novipuspitasari looks out from her clinic and recalls the number of times that floods swallowed roads, landmarks and even entire villages. </p><p>The coastal community she serves is familiar with the ferocity of water. Heavy rains coupled with rising tides and coastal erosion make the area prone not just to flooding but the diseases it brings. \u00a0</p><p>\u201cToday I attended to another suspected leptospirosis patient in the emergency unit,\u201d she shares with concern. \u201cJust last night, we escalated another case from observation in emergency care to inpatient treatment,\u201d she adds. </p><p>Year after year, Dr Lisa has been at the forefront of the fight against leptospirosis, a zoonotic and climate-sensitive disease that can result in mild illness that may progress to a serious and sometimes fatal disease. </p><p>She is one of just a few leptospirosis specialists in Demak, treating patients with symptoms ranging from flu-like illness to kidney failure and Severe Pulmonary Hemorrhagic Syndrome.</p><p><img alt=\"A person wearing a magenta dress and patterned shawl stands in an office setting with the text \" sf-size=\"489719\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03105-2.jpg?sfvrsn=fa955730_3\"/></p><p style=\"text-align:center;\">Dr Lisa standing in front of the RSUD Sultanfatah sign. As one of just a few leptospirosis specialists, she is leading efforts to prevent and control leptospirosis infections. (WHO/Fieni Aprilia)</p><p>\u201cAt first, Leptospirosis barely registered as a concern, even among health professionals,\u201d she explains, adding that as the annual death toll rose, she studied how best to treat it, guided by her academic advisor, Professor Gasem, and with insights obtained from research by the National Research and Innovation Agency. </p><p>\u201cToo often, leptospirosis is misdiagnosed as dengue or typhoid, leading to tragic outcomes when diagnosed and treated too late,\u201d she says ruefully. \u00a0</p><p>Over the past year, however, the tide has started to turn. Since January 2023, World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), USAID-IDDS and the Indonesian Ministry of Health and local government have joined forces to strengthen leptospirosis prevention and control in Demak, which is expected to face rising sea levels and land subsidence of two to eight centimeters per year.</p><p><img alt=\"A patient lying in a hospital bed with medical equipment and a relative standing by their side.\" sf-size=\"434752\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03091-2.jpg?sfvrsn=8048959b_3\"/></p><p style=\"text-align:center;\">A leptospirosis patient undergoing treatment in Demak. As a result of advocacy efforts, the Puskesmas is better prepared and capable of reducing deaths due to leptospirosis. (WHO/Fieni Aprilia)</p><p>Thus far, health and cross-sectoral partners such as the Coordinating Ministry on Human Development and Culture and the Ministry of Agriculture have conducted a joint risk assessment for leptospirosis, developed a series of actionable recommendations to enhance preventive measures, and also established a local zoonosis and emerging infectious disease coordination team, in alignment with the \u201cOne Health\u201d approach, which recognizes the interconnectedness of animal, human and environmental health.</p><p>According to Dr Lisa, these and other initiatives have helped strengthen leptospirosis surveillance and case detection, enhance environmental management and increase rodent trapping, knowledge and awareness-sharing among health workers and the public. </p><p>Lead rodent trapper Amin Sukron agrees. In Bonang village, Amin supervises rodent trapping activities in the homes of leptospirosis survivors, using funds from the village. He has long recognized the correlation between leptospirosis cases and flood-prone areas, where rodents that spread leptospirosis breed. \u00a0</p><p><img alt=\"A person wearing a batik shirt with a name tag reading 'AMIN SURKON' stands in front of a green gate and wall.\" sf-size=\"726871\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03188-2.jpg?sfvrsn=acd3dbaa_3\"/></p><p style=\"text-align:center;\">Amin Sukron, one of the rodent cadres in Bonang Village. (WHO/Fieni Aprilia)</p><p>Amin says that knowledge obtained from Dr Lisa and other health workers at Bonang I Puskesmas has been crucial to strengthening preventive measures, which are most effective when multiple activities are conducted concurrently, with close communication between key actors and the public. </p><p>For this, the One Health approach will continue to be central to WHO, FAO, USAID-IDDS and Ministry of Health and local government efforts. From her clinic in Demak, Dr Lisa reflects positively on the downward trend in leptospirosis cases, in both incidence and severity \u2013 testament, she says, to the collective efforts of partners and the community to protect health and well-being from infectious diseases and the health impacts of climate change.\u00a0\u00a0</p><hr/><p>This activity is supported by the U.S. Government through USAID. <br/><em>Written by Ayunita Mahdy, reporting and documentation officer, WHO Indonesia</em></p></p><p>On a humid and rainy afternoon in Demak District, Central Java health professional Dr Lisa Novipuspitasari looks out from her clinic and recalls the number of times that floods swallowed roads, landmarks and even entire villages. </p><p>The coastal community she serves is familiar with the ferocity of water. Heavy rains coupled with rising tides and coastal erosion make the area prone not just to flooding but the diseases it brings. \u00a0</p><p>\u201cToday I attended to another suspected leptospirosis patient in the emergency unit,\u201d she shares with concern. \u201cJust last night, we escalated another case from observation in emergency care to inpatient treatment,\u201d she adds. </p><p>Year after year, Dr Lisa has been at the forefront of the fight against leptospirosis, a zoonotic and climate-sensitive disease that can result in mild illness that may progress to a serious and sometimes fatal disease. </p><p>She is one of just a few leptospirosis specialists in Demak, treating patients with symptoms ranging from flu-like illness to kidney failure and Severe Pulmonary Hemorrhagic Syndrome.</p><p><img alt=\"A person wearing a magenta dress and patterned shawl stands in an office setting with the text \" sf-size=\"489719\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03105-2.jpg?sfvrsn=fa955730_3\"/></p><img alt=\"A person wearing a magenta dress and patterned shawl stands in an office setting with the text \" sf-size=\"489719\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03105-2.jpg?sfvrsn=fa955730_3\"/><p style=\"text-align:center;\">Dr Lisa standing in front of the RSUD Sultanfatah sign. As one of just a few leptospirosis specialists, she is leading efforts to prevent and control leptospirosis infections. (WHO/Fieni Aprilia)</p><p>\u201cAt first, Leptospirosis barely registered as a concern, even among health professionals,\u201d she explains, adding that as the annual death toll rose, she studied how best to treat it, guided by her academic advisor, Professor Gasem, and with insights obtained from research by the National Research and Innovation Agency. </p><p>\u201cToo often, leptospirosis is misdiagnosed as dengue or typhoid, leading to tragic outcomes when diagnosed and treated too late,\u201d she says ruefully. \u00a0</p><p>Over the past year, however, the tide has started to turn. Since January 2023, World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), USAID-IDDS and the Indonesian Ministry of Health and local government have joined forces to strengthen leptospirosis prevention and control in Demak, which is expected to face rising sea levels and land subsidence of two to eight centimeters per year.</p><p><img alt=\"A patient lying in a hospital bed with medical equipment and a relative standing by their side.\" sf-size=\"434752\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03091-2.jpg?sfvrsn=8048959b_3\"/></p><img alt=\"A patient lying in a hospital bed with medical equipment and a relative standing by their side.\" sf-size=\"434752\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03091-2.jpg?sfvrsn=8048959b_3\"/><p style=\"text-align:center;\">A leptospirosis patient undergoing treatment in Demak. As a result of advocacy efforts, the Puskesmas is better prepared and capable of reducing deaths due to leptospirosis. (WHO/Fieni Aprilia)</p><p>Thus far, health and cross-sectoral partners such as the Coordinating Ministry on Human Development and Culture and the Ministry of Agriculture have conducted a joint risk assessment for leptospirosis, developed a series of actionable recommendations to enhance preventive measures, and also established a local zoonosis and emerging infectious disease coordination team, in alignment with the \u201cOne Health\u201d approach, which recognizes the interconnectedness of animal, human and environmental health.</p><p>According to Dr Lisa, these and other initiatives have helped strengthen leptospirosis surveillance and case detection, enhance environmental management and increase rodent trapping, knowledge and awareness-sharing among health workers and the public. </p><p>Lead rodent trapper Amin Sukron agrees. In Bonang village, Amin supervises rodent trapping activities in the homes of leptospirosis survivors, using funds from the village. He has long recognized the correlation between leptospirosis cases and flood-prone areas, where rodents that spread leptospirosis breed. \u00a0</p><p><img alt=\"A person wearing a batik shirt with a name tag reading 'AMIN SURKON' stands in front of a green gate and wall.\" sf-size=\"726871\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03188-2.jpg?sfvrsn=acd3dbaa_3\"/></p><img alt=\"A person wearing a batik shirt with a name tag reading 'AMIN SURKON' stands in front of a green gate and wall.\" sf-size=\"726871\" src=\"https://www.who.int/images/default-source/searo---images/countries/indonesia/dsc03188-2.jpg?sfvrsn=acd3dbaa_3\"/><p style=\"text-align:center;\">Amin Sukron, one of the rodent cadres in Bonang Village. (WHO/Fieni Aprilia)</p><p>Amin says that knowledge obtained from Dr Lisa and other health workers at Bonang I Puskesmas has been crucial to strengthening preventive measures, which are most effective when multiple activities are conducted concurrently, with close communication between key actors and the public. </p><p>For this, the One Health approach will continue to be central to WHO, FAO, USAID-IDDS and Ministry of Health and local government efforts. From her clinic in Demak, Dr Lisa reflects positively on the downward trend in leptospirosis cases, in both incidence and severity \u2013 testament, she says, to the collective efforts of partners and the community to protect health and well-being from infectious diseases and the health impacts of climate change.\u00a0\u00a0</p><hr/><p>This activity is supported by the U.S. Government through USAID. <br/><em>Written by Ayunita Mahdy, reporting and documentation officer, WHO Indonesia</em></p><br/><em>Written by Ayunita Mahdy, reporting and documentation officer, WHO Indonesia</em>"
    },
    {
        "link": "https://www.who.int/indonesia/news/detail/20-11-2024-empowering-healthcare-educators-through-coaching-programme-for-poltekkes-lecturers",
        "date": "20 November 2024",
        "title": "Empowering healthcare educators through coaching programme for Poltekkes lecturers",
        "thumbnail": "https://cdn.who.int/media/images/default-source/topics/health-systems-and-interventions/health-workforce/20241112-poltekkes-surabaya.tmb-768v.jpg?sfvrsn=f1239844_2",
        "content": "<div><div>The Indonesian Ministry of Health (MoH) and World Health Organization (WHO) have completed an intensive coaching programme to enhance teaching quality at Indonesia's Health Polytechnic (Poltekkes) institutions, addressing the nation's growing demand for skilled healthcare workers. MoH\u2019s 38 Poltekkes play a vital role in producing over 45 000 graduates annually, but a diverse quality of teaching staff poses significant challenges to their effectiveness.</div><div><br/></div><div>The \"Coaching for Poltekkes Lecturers\" programme, implemented from 8 July to 25 August 2024, trained 50 lecturers across four pilot locations in Medan, Yogyakarta, Surabaya and Pontianak. The initiative builds on the 2023 \"Teaching Camp\" and the development of 20 standardized nursing modules.</div><div><br/></div><div>Led by Ai Tanimizu, Technical Officer on Nursing and Midwifery, WHO Regional Office for South-East Asia, and the WHO Indonesia team, the programme delivered week-long intensive coaching sessions at each location. The training included current nursing education updates, micro-teaching sessions and one-on-one coaching. In Pontianak, the team participated in hands-on training in clinical settings at Puskesmas Parit Haji Husin II and Soedarso Pontianak Hospital.</div><div><br/></div><div>\"The programme has significantly enhanced my teaching skills,\" said Marlisa, a lecturer from Poltekkes Medan. \"The coaches provided valuable insights, refining our methods for a more engaging classroom approach. The one-on-one coaching sessions boosted my confidence and inspired me to share this knowledge with students.\"</div><div><br/></div><div>The mission produced comprehensive recommendations for both Poltekkes institutions and MoH. Poltekkes faculty are encouraged to update their knowledge and clinical skills to ensure students receive the most current and proficient training. This includes optimizing laboratory time for practical skill development, emphasizing patient safety and communication, and establishing clear competencies and learning outcomes for each semester. The mission also highlighted the importance of evidence-based teaching and critical thinking.\u00a0</div><div><br/></div><div>For MoH, recommendations include providing English language support for lecturers to enhance their ability to access and disseminate international best practices, and for facilitating cross-institution learning opportunities. MoH is also advised to support lecturer participation in overseas professional development programmes, and to develop a standardized curriculum for the International Nursing Programme. This will ensure a unified and consistent approach to content delivery across all Poltekkes institutions, regardless of their geographical location.\u00a0</div><div><br/></div><div>\"Our collaboration with WHO is a significant step forward in enhancing the quality of Poltekkes education,\u201d said Arianti Anaya, then Director General of Health Workforce, MoH, Government of Indonesia. \u201cBy empowering our faculty with advanced teaching techniques and clinical expertise, we envision a future where our graduates are well prepared to meet the evolving healthcare challenges of our nation.\"\u00a0</div><div style=\"text-align:center;\"><em></em></div><div><br/></div><div>The coaching programme is aligned with the WHO Global Strategic Directions for Nursing and Midwifery 2021\u20132025, which highlights the importance of faculty development in modern pedagogical methods and clinical expertise. It supports implementation of the MoH Strategic Plan 2020\u20132024 and is aligned with the forthcoming National Mid-Term Development Plan 2025\u20132029 (RPJMN).\u00a0\u00a0</div><div><br/></div><div>This investment in pre-service education will accelerate health workforce transformation, ensuring that Poltekkes graduates are well-equipped to provide high-quality care to all Indonesians.\u00a0 \u00a0</div><div><hr/></div><div><em>Written by Zakiyah Eke, National Professional Officer for Health Workforce, WHO Indonesia</em></div></div><div>The Indonesian Ministry of Health (MoH) and World Health Organization (WHO) have completed an intensive coaching programme to enhance teaching quality at Indonesia's Health Polytechnic (Poltekkes) institutions, addressing the nation's growing demand for skilled healthcare workers. MoH\u2019s 38 Poltekkes play a vital role in producing over 45 000 graduates annually, but a diverse quality of teaching staff poses significant challenges to their effectiveness.</div><div><br/></div><br/><div>The \"Coaching for Poltekkes Lecturers\" programme, implemented from 8 July to 25 August 2024, trained 50 lecturers across four pilot locations in Medan, Yogyakarta, Surabaya and Pontianak. The initiative builds on the 2023 \"Teaching Camp\" and the development of 20 standardized nursing modules.</div><div><br/></div><br/><div>Led by Ai Tanimizu, Technical Officer on Nursing and Midwifery, WHO Regional Office for South-East Asia, and the WHO Indonesia team, the programme delivered week-long intensive coaching sessions at each location. The training included current nursing education updates, micro-teaching sessions and one-on-one coaching. In Pontianak, the team participated in hands-on training in clinical settings at Puskesmas Parit Haji Husin II and Soedarso Pontianak Hospital.</div><div><br/></div><br/><div>\"The programme has significantly enhanced my teaching skills,\" said Marlisa, a lecturer from Poltekkes Medan. \"The coaches provided valuable insights, refining our methods for a more engaging classroom approach. The one-on-one coaching sessions boosted my confidence and inspired me to share this knowledge with students.\"</div><div><br/></div><br/><div>The mission produced comprehensive recommendations for both Poltekkes institutions and MoH. Poltekkes faculty are encouraged to update their knowledge and clinical skills to ensure students receive the most current and proficient training. This includes optimizing laboratory time for practical skill development, emphasizing patient safety and communication, and establishing clear competencies and learning outcomes for each semester. The mission also highlighted the importance of evidence-based teaching and critical thinking.\u00a0</div><div><br/></div><br/><div>For MoH, recommendations include providing English language support for lecturers to enhance their ability to access and disseminate international best practices, and for facilitating cross-institution learning opportunities. MoH is also advised to support lecturer participation in overseas professional development programmes, and to develop a standardized curriculum for the International Nursing Programme. This will ensure a unified and consistent approach to content delivery across all Poltekkes institutions, regardless of their geographical location.\u00a0</div><div><br/></div><br/><div>\"Our collaboration with WHO is a significant step forward in enhancing the quality of Poltekkes education,\u201d said Arianti Anaya, then Director General of Health Workforce, MoH, Government of Indonesia. \u201cBy empowering our faculty with advanced teaching techniques and clinical expertise, we envision a future where our graduates are well prepared to meet the evolving healthcare challenges of our nation.\"\u00a0</div><div style=\"text-align:center;\"><em></em></div><em></em><div><br/></div><br/><div>The coaching programme is aligned with the WHO Global Strategic Directions for Nursing and Midwifery 2021\u20132025, which highlights the importance of faculty development in modern pedagogical methods and clinical expertise. It supports implementation of the MoH Strategic Plan 2020\u20132024 and is aligned with the forthcoming National Mid-Term Development Plan 2025\u20132029 (RPJMN).\u00a0\u00a0</div><div><br/></div><br/><div>This investment in pre-service education will accelerate health workforce transformation, ensuring that Poltekkes graduates are well-equipped to provide high-quality care to all Indonesians.\u00a0 \u00a0</div><div><hr/></div><hr/><div><em>Written by Zakiyah Eke, National Professional Officer for Health Workforce, WHO Indonesia</em></div><em>Written by Zakiyah Eke, National Professional Officer for Health Workforce, WHO Indonesia</em>"
    },
    {
        "link": "https://www.who.int/indonesia/news/detail/19-11-2024-new-who-regional-strategy-supports-indonesia-s-mission-to-end-ntds-by-2030",
        "date": "19 November 2024",
        "title": "New WHO regional strategy supports Indonesia\u2019s mission to end NTDs by 2030",
        "thumbnail": "https://cdn.who.int/media/images/default-source/cover-images/publication-banner-(4).tmb-768v.png?sfvrsn=565672ea_2",
        "content": "<div><p><img src=\"\"/></p><p>The WHO Regional Strategic Framework for sustaining, accelerating and innovating to end neglected tropical diseases (NTDs) in the South-East Asia Region 2024\u20132030 adopts a comprehensive, people-centred approach to end NTDs, a diverse group of conditions that are mainly prevalent among impoverished communities in tropical areas.\u202f\u202f\u00a0</p><p>Globally, NTDs affect more than 1 billion people. An estimated 1.6 billion people require NTD interventions, both preventive and curative. In Indonesia, NTDs affect an estimated 80 million people \u2013 around 29% of the total population. Of 21 NTDs globally, 11 are endemic in Indonesia. These include lymphatic filariasis (LF), soil-transmitted helminthiasis, taeniasis, schistosomiasis, leprosy, yaws, dengue, chikungunya, scabies, rabies and venomous snake bites.\u202f\u00a0</p><p>The Regional Framework promotes cross-cutting and integrated action that brings together public health programmes, governments, civil society, communities and development partners. It highlights the latest scientific evidence and gaps, incorporates lessons learned from past endeavours, and accounts for the evolving global and regional health landscape.\u202f\u202f\u00a0</p><p>Across Indonesia, the Framework continues to inform NTD activities and planning. The country\u2019s forthcoming Medium-Term Development Plan 2025-2029 prioritizes the elimination of three skin-related NTDs \u2013 LF, leprosy and yaws \u2013 and aims to control dengue and rabies.\u202f \u202f\u00a0</p><p>Download the Strategic Framework here:\u202f<a href=\"https://www.who.int/publications/i/item/9789290211327\" rel=\"noreferrer noopener\" target=\"_blank\">Regional Strategic Framework for sustaining, accelerating and innovating to end neglected tropical diseases in the South-East Asia Region, 2024\u20132030</a>\u00a0</p></div><p><img src=\"\"/></p><img src=\"\"/><p>The WHO Regional Strategic Framework for sustaining, accelerating and innovating to end neglected tropical diseases (NTDs) in the South-East Asia Region 2024\u20132030 adopts a comprehensive, people-centred approach to end NTDs, a diverse group of conditions that are mainly prevalent among impoverished communities in tropical areas.\u202f\u202f\u00a0</p><p>Globally, NTDs affect more than 1 billion people. An estimated 1.6 billion people require NTD interventions, both preventive and curative. In Indonesia, NTDs affect an estimated 80 million people \u2013 around 29% of the total population. Of 21 NTDs globally, 11 are endemic in Indonesia. These include lymphatic filariasis (LF), soil-transmitted helminthiasis, taeniasis, schistosomiasis, leprosy, yaws, dengue, chikungunya, scabies, rabies and venomous snake bites.\u202f\u00a0</p><p>The Regional Framework promotes cross-cutting and integrated action that brings together public health programmes, governments, civil society, communities and development partners. It highlights the latest scientific evidence and gaps, incorporates lessons learned from past endeavours, and accounts for the evolving global and regional health landscape.\u202f\u202f\u00a0</p><p>Across Indonesia, the Framework continues to inform NTD activities and planning. The country\u2019s forthcoming Medium-Term Development Plan 2025-2029 prioritizes the elimination of three skin-related NTDs \u2013 LF, leprosy and yaws \u2013 and aims to control dengue and rabies.\u202f \u202f\u00a0</p><p>Download the Strategic Framework here:\u202f<a href=\"https://www.who.int/publications/i/item/9789290211327\" rel=\"noreferrer noopener\" target=\"_blank\">Regional Strategic Framework for sustaining, accelerating and innovating to end neglected tropical diseases in the South-East Asia Region, 2024\u20132030</a>\u00a0</p><a href=\"https://www.who.int/publications/i/item/9789290211327\" rel=\"noreferrer noopener\" target=\"_blank\">Regional Strategic Framework for sustaining, accelerating and innovating to end neglected tropical diseases in the South-East Asia Region, 2024\u20132030</a>"
    }
]